Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source

7Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.
Get full text

Abstract

To the Editor: Hart et al. (June 7 issue)1 report the results of the NAVIGATE ESUS (New Approach Rivaroxaban Inhibition of Factor Xa in a Global Trial versus ASA to Prevent Embolism in Embolic Stro...

Cite

CITATION STYLE

APA

Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. (2018). New England Journal of Medicine, 379(10), 986–987. https://doi.org/10.1056/nejmc1809065

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free